Cervical Cancer In Women
Cervical cancer it the fourth most common cancer in women globally, with an estimated 604,000 new cases and 342,00 deaths in 2020.
Human papillomavirus (HPV) is a common sexually transmitted infection which can affect the skin, genital area and throat. Almost all sexually active people will be infected at some point in their lives, usually without symptoms. In most cases the immune system clears HPV from the body. Persistent infection with high-risk HPV can cause abnormal cells to develop, which go on to become cancer. Women living with HIV are 6 times more likely to develop cervical cancer compared to women without HIV.
Early Detection Is Key
Cervical cancer can be cured if diagnosed and treated at an early stage of disease. Recognizing symptoms and seeking medical advice to address any concerns is a critical step. Women should see a healthcare professional if they notice:
- unusual bleeding between periods, after menopause, or after sexual intercourse
- increased or foul-smelling vaginal discharge
- symptoms like persistent pain in the back, legs, or pelvis
- weight loss, fatigue and loss of appetite
- vaginal discomfort
- swelling in the legs.
Prophylactic vaccination against HPV and screening and treatment of pre-cancer lesions are effective ways to prevent cervical cancer and are very cost-effective.
Cervical cancer can be cured if diagnosed at an early stage and treated promptly.
Countries around the world are working to accelerate the elimination of cervical cancer in the coming decades, with an agreed set of three targets to be met by 2030.
Reference: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
